FDA Inspection
SUN PHARMACEUTICAL INDUSTRIES INCSUN PHARMACEUTICAL INDUSTRIES INC – FDA Inspection, Mar 20, 2017
Record Details
This FDA Inspection record concerns SUN PHARMACEUTICAL INDUSTRIES INC, with an inspection on March 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Parul M. Patel (Company Rep)
- Yvesna C. Blaise (Issuing Officer)
View Company Profile
ID · c5afb702-c14c-4571-9e4e-2d464a194e41
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005521
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.188(b)(11)Identification of Persons Performing Significant Steps
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SUN PHARMACEUTICAL INDUSTRIES INC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2026 | Not classified | New Jersey District Office | Bioresearch Monitoring |
| December 12, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 10, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 8, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 18, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SUN PHARMACEUTICAL INDUSTRIES INC
- FDA Inspection 1328400 - 2026-07-24
- FDA Inspection 1230974 - 2024-12-12
- FDA Inspection 1179668 - 2022-08-10
- FDA Inspection 1083409 - 2019-03-08
- FDA Inspection 1068971 - 2018-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.